APP and Alzheimer disease: In contrast to widely used transgenic mice that express multiple mutant AD-genes and develop an early onset of disease27, APP23 mice overexpress the Swedish APP double mutation which does not affect the survival rates and leads to the development of pathological hallmarks and learning deficits with increasing age28, 29.